LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a ...
Go-forward strategy will emphasize topline revenue growth and future profitability. Company to reduce total operating costs by an estimated 15% in fiscal year 2025. The restructuring will allow ...
iRobot transferred all of its equity to Shenzhen Picea Robotics and said it will launch a U.S. subsidiary to protect U.S. consumer data as it emerges from the chapter 11 bankruptcy process The maker ...
Are your IT teams still achieving maximum productivity and efficiency? If not, it may be a sign that it’s time for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results